TELA Bio (TELA) Total Current Liabilities (2018 - 2026)

TELA Bio has reported Total Current Liabilities for 9 years, with the latest figure at $17.8 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 7.84% year-over-year to $17.8 million; the trailing twelve-month figure through Mar 2026 stood at $17.8 million (up 7.84% YoY), and the FY2025 full-year result was $18.0 million, up 15.24% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $17.8 million, down from $18.0 million in the prior quarter.
• The five-year high for Total Current Liabilities was $19.1 million in Q2 2025, with the low at $11.9 million in Q2 2022.
• Average Total Current Liabilities over 5 years is $15.4 million, with a median of $15.3 million recorded in 2023.
• Year-over-year, Total Current Liabilities jumped 117.91% in 2022 and slipped 8.07% in 2024.
• Tracing TELA's Total Current Liabilities over 5 years: stood at $12.4 million in 2022, then jumped by 36.8% to $17.0 million in 2023, then fell by 8.07% to $15.6 million in 2024, then gained by 15.24% to $18.0 million in 2025, then decreased by 0.79% to $17.8 million in 2026.
• The last three Total Current Liabilities figures came in at $17.8 million (Q1 2026), $18.0 million (Q4 2025), and $17.0 million (Q3 2025), per Business Quant data.

Peer Comparison